Pseudomonas aeruginosa Endophthalmitis: Clinical Outcomes and Antibiotic Susceptibilities

Ocular Immunology and Inflammation
Khalil Ghasemi FalavarjaniArash Pourhabibi

Abstract

To report the clinical characteristics, antibiotic susceptibilities, and visual outcomes for eyes with endophthalmitis caused by Pseudomonas aeruginosa. In this retrospective, non-comparative case series, medical records of eyes with culture-proven Pseudomonas aeruginosa endophthalmitis, who were treated from April 2005 to April 2015 at a referral center in Tehran were reviewed. Clinical features, antibiotic susceptibilities, and visual outcomes were assessed. In total, 20 eyes of 19 patients were identified. The clinical settings included cataract surgery (85%), pars plana vitrectomy (5%), endogenous source (5%), and intravitreal bevacizumab injection (5%). Presenting visual acuity ranged from 20/120 to no light perception. Pars plana vitrectomy with intravitreal antibiotic injection was performed as the initial treatment in 16 eyes (80%). The organisms were sensitive to ciprofloxacin and imipenem in 100%; amikacin in 88.3%; ceftazidime in 83.4%; and tobramycin in 83.4% of isolates tested. Final visual acuity was hand motions or worse in 18 eyes (90%). Evisceration was performed in five eyes (20%). Susceptibility to ciprofloxacin and imipenem was found in all isolates tested. Despite appropriate treatment, visual and anatomic ...Continue Reading

References

Sep 1, 1984·Reviews of Infectious Diseases·M Pollack
Jul 1, 1996·American Journal of Ophthalmology·D P HanS F Kelsey
Jul 26, 2005·Journal of Cataract and Refractive Surgery·Sengül C OzdekBerati Hasanreisoğlu
Aug 19, 2007·Indian Journal of Ophthalmology·Mohsen Bahmani KashkouliMasood Naseripour
May 24, 2008·Journal of Cataract and Refractive Surgery·Narman Puvanachandra, Roger C Humphry
Oct 10, 2009·Ophthalmology·Antonio PinnaJayaraman Kaliamurthy
Feb 2, 2011·Retina·Kuan-Jen ChenJane Zea-Chin Kuo
Jul 9, 2011·American Journal of Infection Control·Helena C MaltezouPavlos Nicolaidis
Dec 19, 2012·Middle East African Journal of Ophthalmology·Khalil Ghasemi FalavarjaniSayyed Amirpooya Alemzadeh
Apr 1, 2015·Clinical & Experimental Ophthalmology·Van C LansinghGlenn Strauss
Nov 10, 2015·Retina·Jayanth SridharDarlene Miller

❮ Previous
Next ❯

Citations

Oct 19, 2017·Ocular Immunology and Inflammation·Sumayya AhmadGuillermo Amescua
Jan 18, 2020·Ocular Immunology and Inflammation·Sara SpeltaMarco Coassin
May 18, 2019·Journal of Ophthalmic Inflammation and Infection·Tarjani Vivek DaveTaraprasad Das
May 11, 2021·FEMS Microbiology Reviews·Andreu Coello PelegrinAlex van Belkum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.